| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Other | 67.3K | $10.51M | - | |
| Other | 56.8K | $8.87M | - | |
| CFO | 42.8K | $6.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 19,818 | $133.36 | $2,643,019.64 | -32.7% | +11.9% | -27.0% | |
| Apr 1, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 272 | $137.30 | $37,345.60 | -3.5% | -0.9% | -24.3% | |
| Mar 21, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 5,000 | $145.06 | $725,320.00 | -40.0% | -6.7% | -22.1% | |
| Mar 14, 2024 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 75,000 | $139.38 | $10,453,417.50 | -64.8% | -3.3% | -20.4% | |
| Mar 14, 2024 | Morrow George J71 | Director | Sale+OE | 40,000 | $139.42 | $5,576,710.00 | -100% | -3.3% | -20.4% | |
| Mar 13, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 3,000 | $140.14 | $420,419.40 | -28.6% | -6.1% | -23.1% | |
| Mar 13, 2024 | Pops Richard F57 | Director | Sale+OE | 23,200 | $140.33 | $3,255,621.20 | -44.0% | -6.1% | -23.1% | |
| Mar 11, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 2,000 | $140.03 | $280,052.56 | -21.0% | -2.8% | -22.6% | |
| Mar 11, 2024 | Pops Richard F57 | Director | Sale+OE | 1,800 | $140.04 | $252,078.03 | -5.7% | -2.8% | -22.6% | |
| Feb 29, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE | 6,817 | $135.34 | $922,631.73 | -47.6% | +3.2% | -9.0% |